Fennec Pharmaceuticals's Earnings Outlook
Portfolio Pulse from Benzinga Insights
Fennec Pharmaceuticals (NASDAQ:FENC) is scheduled to release its quarterly earnings report on Thursday, 2024-03-21, with an expected EPS of $-0.02. Analysts and investors are keen on not just the earnings beat but also the company's guidance for future growth. Historically, FENC has shown a mixed performance in beating EPS estimates, with the last quarter showing a beat that led to a 2.51% increase in share price. Over the last year, FENC shares have risen by 50.54%, indicating a bullish sentiment among long-term shareholders.
March 20, 2024 | 5:01 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Fennec Pharmaceuticals is expected to report an EPS of $-0.02 for the upcoming quarter. Historical performance shows a mixed reaction to earnings reports, with the last quarter's beat leading to a 2.51% increase in share price. Shares have increased by 50.54% over the last year.
Given Fennec Pharmaceuticals' recent history of beating EPS estimates and the subsequent positive impact on its share price, coupled with a significant annual increase in share value, there is a strong likelihood of a positive short-term impact on FENC's stock price if the company reports favorable earnings and guidance.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100